These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30796191)

  • 21. Contrast between class I and class II MHC-mediated differentiation of a CD4+CD8+ T cell line: implications for lineage commitment.
    DeKoning J; Carbone FR; Kaye J
    Int Immunol; 1995 Apr; 7(4):541-9. PubMed ID: 7547680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms.
    Ge Q; Holler PD; Mahajan VS; Nuygen T; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1822-7. PubMed ID: 16443680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of peripheral and intestinal T lymphocytes lacking CD3 zeta.
    Simpson S; Holländer G; She J; Levelt C; Huang M; Terhorst C
    Int Immunol; 1995 Feb; 7(2):287-93. PubMed ID: 7734423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of innate-like T cells and their selection by MHC class I-like molecules.
    Edholm ES; Banach M; Robert J
    Immunogenetics; 2016 Aug; 68(8):525-36. PubMed ID: 27368412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.
    Kaye J; Hsu ML; Sauron ME; Jameson SC; Gascoigne NR; Hedrick SM
    Nature; 1989 Oct; 341(6244):746-9. PubMed ID: 2571940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective association between MHC class I-restricted T cell receptors, CDS, and activated tyrosine kinases on thymocytes undergoing positive selection.
    Carrera AC; Wee SB; Roberts TM; Pardoll DM
    J Immunol; 1992 Nov; 149(10):3142-9. PubMed ID: 1431093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How nonuniform contact profiles of T cell receptors modulate thymic selection outcomes.
    Chen H; Chakraborty AK; Kardar M
    Phys Rev E; 2018 Mar; 97(3-1):032413. PubMed ID: 29776088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell receptor repertoires utilized in response to linear peptides representing an immunodominant MHC class II restricted T-cell epitope are far more diverse than that utilized in response to the same epitope in the nominal antigen.
    Huang CC; Ts'ao PY; Manser T
    Mol Immunol; 1998 Apr; 35(5):279-91. PubMed ID: 9747888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
    Marusić-Galesić S; Walden P
    Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the drivers of MHC restriction of T cell receptors.
    La Gruta NL; Gras S; Daley SR; Thomas PG; Rossjohn J
    Nat Rev Immunol; 2018 Jul; 18(7):467-478. PubMed ID: 29636542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The constitutive tyrosine phosphorylation of CD3zeta results from TCR-MHC interactions that are independent of thymic selection.
    Becker AM; DeFord-Watts LM; Wuelfing C; van Oers NS
    J Immunol; 2007 Apr; 178(7):4120-8. PubMed ID: 17371967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class II major histocompatibility complex mutant mice to study the germ-line bias of T-cell antigen receptors.
    Silberman D; Krovi SH; Tuttle KD; Crooks J; Reisdorph R; White J; Gross J; Matsuda JL; Gapin L; Marrack P; Kappler JW
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5608-17. PubMed ID: 27588903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire.
    Fry AM; Cotterman MM; Matis LA
    J Immunol; 1989 Oct; 143(8):2723-9. PubMed ID: 2477456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms.
    Reche PA; Reinherz EL
    J Mol Biol; 2003 Aug; 331(3):623-41. PubMed ID: 12899833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How TCRs bind MHCs, peptides, and coreceptors.
    Rudolph MG; Stanfield RL; Wilson IA
    Annu Rev Immunol; 2006; 24():419-66. PubMed ID: 16551255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized.
    Maryanski JL; Casanova JL; Falk K; Gournier H; Jaulin C; Kourilsky P; Lemonnier FA; Lüthy R; Rammensee HG; Rötzschke O; Servis C; López JA
    Hum Immunol; 1997 May; 54(2):117-28. PubMed ID: 9297530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.